Back to School: How biopharma can reboot drug development. Access exclusive analysis here

BMS-247550: Phase II

In a Phase II trial in metastatic breast cancer refractory

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE